Profile
Mr. Takashi Nagamachi is President at Ajinomoto Pharmaceuticals Co., Ltd.
He is on the Board of Directors at Ajinomoto Co., Inc.
He received his undergraduate degree from Keio University.
Former positions of Takashi Nagamachi
Companies | Position | End |
---|---|---|
AJINOMOTO CO., INC. | Director/Board Member | - |
EA Pharma Co., Ltd.
EA Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., EA Pharma Co., Ltd. is a specialty pharmaceutical company based in Tokyo, Japan. The Japanese company specializes in digestive diseases such as inflammatory intestinal diseases and focuses on advanced research and development and marketing activities to solve unmet medical needs. EA Pharma Co. provides drug discovery research, development research related to gastrointestinal diseases, and drug discovery base technology research to meet the further medical needs of patients. The company's production department aims to create products that have effective and safety as a drug and ensure the quality of the product. EA Pharma Co. aims to be the largest digestive pharmacy in Japan, which was born in the integration of the digestive business of the Eisai group and the Ajinomoto group's digestive business. | Chief Executive Officer | - |
Training of Takashi Nagamachi
Keio University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
AJINOMOTO CO., INC. | Consumer Non-Durables |
Private companies | 1 |
---|---|
EA Pharma Co., Ltd.
EA Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., EA Pharma Co., Ltd. is a specialty pharmaceutical company based in Tokyo, Japan. The Japanese company specializes in digestive diseases such as inflammatory intestinal diseases and focuses on advanced research and development and marketing activities to solve unmet medical needs. EA Pharma Co. provides drug discovery research, development research related to gastrointestinal diseases, and drug discovery base technology research to meet the further medical needs of patients. The company's production department aims to create products that have effective and safety as a drug and ensure the quality of the product. EA Pharma Co. aims to be the largest digestive pharmacy in Japan, which was born in the integration of the digestive business of the Eisai group and the Ajinomoto group's digestive business. | Health Technology |
- Stock Market
- Insiders
- Takashi Nagamachi